CNN: MAHA Pharma Ad Ban ‘Could Cripple Some Broadcasters’

Contact Your Elected Officials

Don’t threaten me with a good time, CNN!

In lieu of a total pharma ad ban that may or may not be feasible through executive action, the Trump administration is reportedly mulling two policy changes to limit pharma’s propaganda capacity through the legacy corporate state media, heavily dependent on ad cash to finance its lavish and increasingly unpopular programming.

Via Bloomberg (emphasis added):

“The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to advertise directly to patients, in a move that could disrupt more than $10 billion in annual ad spending…

The two policies the administration has focused in on would be to require greater disclosures of side effects of a drug within each ad — likely making broadcast ads much longer and prohibitively expensive — or removing the industry’s ability to deduct direct-to-consumer advertising as a business expense for tax purposes, these people said.”

Related: In 2025, WebMD Claims COVID Vax ‘Still Crucial for Children’

While failing to disclose its own interests in keeping the gravy train rolling, CNN cites concerns among generic “broadcasters” that would stand to lose out on a critical source of revenue.

Via CNN (emphasis added):

“For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between TV segments. But a pair of policies being considered by US Health and Human Services Secretary Robert F. Kennedy Jr. could change that and leave broadcasters in financial straits.

While not an outright ban*, the two policies would make it significantly more difficult and expensive for drug companies to push their products across broadcasters’ airwaves… The policies look to either mandate that advertisers elaborate on the risks posed by their drugs — forcing ads to be longer and, therefore, more expensive — or bar drugmakers from writing off direct-to-consumer ads as business expenses on their taxes, also padding the bill.”

Of course, if the American Congress were worth a damn, it would have long ago rendered these proposed executive actions moot by outright banning the ads — but it won’t, because both parties are nearly entirely comprised of bought and paid for prostitutes.

Related: MAHA: Top FDA Vax-Monger’s Firing Sends Pharma Stocks Plummeting

Without pharma ads — and captive audiences in airports and bars and waiting rooms to artificially inflate its audience stats and the preferential access granted by the political class — CNN would be totally fucked.

As you might recall, human-potato hybrid Brian Stelter humiliated himself at the National Press Club in 2018 when he attempted to assert that his network doesn’t actually care about ratings and is instead devoted purely to news reporting.

Derisive laughter right in his overfed face ensued, followed later by his unceremonial firing.

Ben Bartee
Ben Barteehttps://armageddonprose.substack.com/
BEWARE!!! Ben Bartee never minces words, so read at your own risk. Ben is a Bangkok-based American journalist, grant writer, political essayist, researcher, travel blogger, and amateur philosopher -- with opposable thumbs. He is the author of Broken English Teacher: Notes From Exile.

Liberal Democrat Content Creators are Despicable Defamationers

What should Christian conservatives do when confronted with false information to the point of bearing false witness against someone like President Trump?

Ben Shapiro Warning Me Not to Listen to InfoWars Makes Me Want to Listen 10x Harder

This rant from Ben Shapiro reveals more about him and his low opinion of his audience to whom he peddles his slop than it does about its target, Alex Jones.

Epstein’s Aftermath: Planes, Blames, and Autocrats

There are so many real, honest great journalists reporting the news on the internet these days that some really good content gets overlooked.

Why the Trump Administration is Sitting on the Epstein Files

President Trump, AG Bondi, and FBI Dir. Patel have the advantage over us in that they see the big overall picture when it comes to the Epstein List.

Trump’s “Major Statement” On Russia Is A Clumsy Attempt To Thread The Needle

The “major statement” on Russia Trump hyped up turned out to be an attempt to thread the needle between escalating US involvement in Ukrainian and walking away from it.

7.3 Magnitude Earthquake Hits Off Alaska Coast; Tsunami Warning Issued

A 7.3-magnitude earthquake struck off the coast of southern Alaska prompting federal officials to issue a tsunami warning.

University of Southern California Faces $300 Million in Federal Funding Cuts, Staff Layoffs

USC faces potential revenue loss of hundreds of millions of dollars in federal funds and staff layoffs, amid "volatile external environment,” Interim President says.

Florida AG Threatens Lawsuit Against US Masters Swimming Over Male Participation in Female Events

FL AG James Uthmeier, in a letter to CEO of U.S. Masters Swimming, called for immediate end to male athletes participating in female competitions by organization.

The Market’s Focus Returns to Tariffs

Surging tariff revenue is expected to help the Treasury Department better manage the federal government budget deficit.

EU’s Trade Chief to Meet With US Officials as EU Braces for Tariff Showdown

The EU’s trade leader is headed to Washington for face-to-face negotiations with the Trump admin, a spokesman for the economic bloc said.

Nvidia’s AI Chip Sales to China Tied to Rare Earths Trade Talks, Says Commerce Secretary

USs’ decision to allow Nvidia to resume selling China AI chips is tied to recent trade negotiations over rare-earth exports, according to Sec Lutnick.

Trump Says US–Vietnam Trade Deal Nearly Complete

President Trump said the trade deal between the United States and Vietnam was nearly complete, the same day he announced a new deal with Indonesia.

Washington Announces Investigation Into Brazilian Trade Practices, Digital Payment Services

U.S. Trade Representative Jamieson Greer announced the opening of an investigation into Brazil’s “unfair” trading practices on July 15, 2025.
spot_img

Related Articles